Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment
Insilico’s candidate demonstrated a favorable profile with good in vivo efficacy at low doses, efficient synthesis, and no need for co-administration with Ritonavir. The candidate is intended to be used for the treatment of SARS-CoV-2 and its variants, along with...
ICP DAS - BMP will attend Medical Taiwan Expo 2022 in Taipei
TAIPEI, May 25, 2022 /PRNewswire/ — ICP DAS – BMP (Biomedical Polymers), a Taiwanese medical TPU (thermoplastic polyurethane) supplier, will exhibit at Medical Taiwan 2022, an international medical, health, and care expo. The Medical Taiwan Expo 2022 will take place at...
CGTN: The key Xi Jinping learned from his father
BEIJING, May 24, 2022 /PRNewswire/ — "There are many noble characters I wish to inherit from my father," Xi Jinping, then governor of east China’s Fujian Province, said in a letter of felicitation to his father Xi Zhongxun on his birthday...